Sodium pyridine-2-sulfinate

Catalog No.: 
ACOVBU957
CAS No.: 
24367-66-6
Molecular Formula: 
C5H4NNaO2S
Molecular Weight: 
165.15
Sodium pyridine-2-sulfinate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$61.00In stockIn stock
250mg95%$88.00In stockIn stock
1g95%$231.00In stockInquiry
5g95%$695.00In stockInquiry
25g95%$2585.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameSodium pyridine-2-sulfinate
IUPAC NameSodium pyridine-2-sulfinate
MDL No.MFCD20483664
Molecular FormulaC5H4NNaO2S
Molecular Weight165.15
SMILESO=S(C1=NC=CC=C1)[O-].[Na+]
InChI KeyHQCGASCBCQJRDJ-UHFFFAOYSA-M
SynonymSCHEMBL1127243 | CS-0155833 | pyridine-2-sulfinate sodium salt | AKOS022189955 | sodium 2-pyridinesulfinate | pyridine-2-sulfinic acid sodium salt | Sodium pyridine-2-sulfinate | sodium;pyridine-2-sulfinate | A1-44732 | Sodium pyridine-2-sulfinate, >=95%
CAS No.24367-66-6
PubChem CID23678794

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACOVBU957 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOVBU957 route product structure diagram
    ACOVBU95724367-66-6In Stock
Inquiry

2. ACOVBU957 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOVBU957 route product structure diagram
    ACOVBU95724367-66-6In Stock
Inquiry

3. ACOVBU957 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOVBU957 route product structure diagram
    ACOVBU95724367-66-6In Stock
Inquiry

Comments (0)